Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank89
5Y CAGR+114.0%
Year-over-Year Change
Price-to-sales ratio
5Y CAGR
+114.0%/yr
Long-term compound
Percentile
P89
Within normal range
vs 5Y Ago
44.9x
Strong expansion
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 215.18 | -89.8% |
| 2023 | 2109.97 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | -100.0% |
| 2019 | 4.79 | +42.2% |
| 2018 | 3.37 | -53.5% |
| 2017 | 7.25 | -33.3% |
| 2016 | 10.87 | +20.9% |
| 2015 | 9.00 | - |